Navigation Links
Senate assures ban on smoking

cades ago, and those in favor of scrapping the Sunday liquor law argued it was unfair to restrict liquor stores when other retailers were allowed to operate on Sundays. They predict that ending the prohibition will increase the state's annual sales tax revenue by about $1.8 million.

But many Massachusetts mom-and-pop liquor store owners opposed the change, saying it will create pressure for them to work on what is now their only day off, according to the 700-member strong Massachusetts Package Stores Association. Some religious leaders also are loath to give up one of the last laws that distinguishes Sunday from other days.

In 1990, the Massachusetts Legislature relaxed alcohol rules to allow Sunday sales between Thanksgiving and New Year's Day and in cities and towns within 10 miles of New Hampshire and Vermont, which permit Sunday sales. Border legislators determined to preserve that competitive advantage helped doom a House attempt to lift the ban last month. But the measure was presented as a separate bill, and the idea's inclusion in a broader measure helped push it through last night.

"Modernizing the marketplace by allowing Sunday sales will bring consumers more convenience and the state more tax revenue," said David Wojnar of the Washington-based Distilled Spirits Council, which lobbied heavily for the measure.

In other action, legislative leaders delayed action on a property tax bill pushed by Mayor Thomas M. Menino of Boston and other local officials. Menino and his aides had lobbied furiously for the bill, arguing that without it, the average Boston homeowner would see an $800 property tax increase next year. As many as 50 other communities around the state also would benefit from the measure, which would allow cities to raise commercial tax rates beyond the current limits to deal with a rare divergence between residential property values, which are going up, and stagnant commercial values.


'"/>




Page: 1 2 3 4

Related medicine news :

1. US Senate Votes against Testing of Pesticide on Humans
2. US Senate Approves Embryo-research Plan Despite Presidents Refusal
3. Senate Committee Approves Telemedicine Mental Health Bill
4. US Senate Passes Stem Cell Research Bill
5. Vaccine to quit smoking?
6. ZYBAN, The smoking cessation drug marked for its adverse reactions
7. A boost to quit smoking
8. Quitting smoking stops lung decline
9. Passive smoking affects respiratory system
10. Stop smoking and reduce weight
11. Teens listen to parents about smoking
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Senate assures ban smoking

(Date:5/12/2008)...ll Webcast Monday, May 12, 08:30 a.m. EDT at ...CARLSBAD, Calif., May 12 /PRNewswire-FirstCall/ --... announced its financial results,for the quarter e...ter with,a pro forma net operating loss (NOL) of $...d to stock options, compared to a pro forma NOL,of...
(Date:5/12/2008)...RNewswire-FirstCall/ -- InfuSystem Holdings, Inc.,...ing provider of,ambulatory infusion pumps and asso...l results and provided a business update for the f...xecutive officer, commented, "We are pleased,with ...s as a stand-alone,public company, and have alread...
(Date:5/12/2008)... Nail Fungus and the Dreaded Summer Yeast Infectio...the pleasures of summer,abound, warm weather also ...en,t prepared for., Feel your best with these hea...ome elusive summertime pitfalls., From The Top --...ter,just one hour of exposure, hair begins sheddin...
(Date:5/11/2008)...1 /PRNewswire/ -- As the global community observes...ost deadly cyclone of all,time and the associated ...,for cyclone victims, the Alumni Myanmar Institute...ve-and more importantly, successful-in initiating,...r where 100,000 people,are assumed dead. AMIMA has...
Breaking Medicine News(10 mins):Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 2Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 3Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 4Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 5Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 6Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 7Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 8Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 9Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 10Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 11Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 12Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 13Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 14Health News:InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results 2Health News:InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results 3Health News:InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results 4Health News:InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results 5Health News:InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results 6Health News:InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results 7Health News:InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results 8Health News:InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results 9Health News:A Woman's Summertime Guide to Healthy Living From Head-to-Toe 2Health News:A Woman's Summertime Guide to Healthy Living From Head-to-Toe 3Health News:Alumni Myanmar Institutes of Medicine Association (AMIMA) Races Time to Help Cyclone Victims 2
...cted on petrochemical workers health and their ret...arly have nearly double the death rate of those wh...pproves the existing misconception that people who...er and happier lives as a consequence. Men were f...
...ly associated with good health and vitality. Howev...the body to manufacture vitamin D. //It doesn't ta... use certainly far less than it takes to get a su... better understand the complex motivations involve...
...in is being hailed as a new 'wonder drug' after it...cancer patients. New results of the trials show th...or the cancer, something that has never happened s...h tracked 5,000 patients in 39 countries, research...
...urvey conducted by Synovate India and sponsored by...gh Indians use high quality toothbrush and the lat...l of oral hygiene awareness was surprisingly low. ...tted that they have never been to a dentist in the...
Other Medicine News:
(Date:5/8/2008)...ovement in ADHD symptoms in adults, WASHINGTON, M...,Nasdaq: SHPGY), the global specialty biopharmace...hase III pivotal study in which VYVANSE,demonstrat...yperactivity,Disorder (ADHD) symptoms in adults an... with ADHD often find it challenging to focus and ...
(Date:5/8/2008)...FirstCall/ -- Siemens Healthcare and,Laboratory Co...y announced,that they have entered a non-exclusive...evelop new clinical diagnostic tests in the areas ...logy and diabetes. Under the,agreement, initial di...could make the biggest impact to patient care., (...
(Date:5/8/2008)...eeting of the American Pain Society ...wswire/ -- Patients treated with lacosamide,demons...thic pain (DNP),compared to placebo-treated patie...l meeting of the American Pain Society (APS) in Ta...trial of a diabetic neuropathic,pain treatment pro...
(Date:5/8/2008)...-FirstCall/ -- AstraZeneca (NYSE:,AZN) today annou...lication,(sNDA) to the U.S. Food and Drug Administ...ate) Extended-Release Tablets to seek approval for...D), including maintenance of,antianxiety effect. I...n,atypical antipsychotic medicine in GAD. The subm...
Breaking Medicine Technology:Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 2Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 3Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 4Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 5Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 2Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 3Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 4New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 2New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 3New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 4AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 2AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 3AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 4AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 5AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 6AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 7AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 8McMaster test detects the most prevalent respiratory viruses 10289 1McMaster test detects the most prevalent respiratory viruses 10289 2Millennium Biotechnologies Group Reports 40 25 Sales Increase for Resurgex Product Line in Greek Market 2785 1Millennium Biotechnologies Group Reports 40 25 Sales Increase for Resurgex Product Line in Greek Market 2785 2Liquent Insight Publisher 3 6 Delivers Advanced Submission Capabilities 10286 1Liquent Insight Publisher 3 6 Delivers Advanced Submission Capabilities 10286 2Drop of Flu Vaccine Under Tongue Bars Infection 10284 1Drop of Flu Vaccine Under Tongue Bars Infection 10284 2
Facilitates one-lung ventilation when using dual lumen endobronchial tubes.
...lbroncho is a double lumen tube made of silicone r...p., ,Due to the characteristics of silicone rubbe...ient at insertion. Furthermore, the tube will not ...ble for long term surgery., ,Silbronco is also es...
Used for endobronchial blockade of the left or right lung for procedures which require one-lung ventilation. The set consists of an endobronchial blocker catheter and an Arndt Multiport Airway Adapte
...e Mini-Trach® II kit includes a guarded scalpe...ISO connector, and a 10fr suction catheter., ,The...ponents needed to perform a cricothyrotomy., ,Wit... (4.0 mm I.D.) is inserted into the trachea throug...
Medicine Products: